Accéder au contenu
Merck

Interaction of drug based binuclear mixed-ligand complexes with DNA.

Bioorganic & medicinal chemistry (2009-07-08)
Mohan N Patel, Mehulsinh R Chhasatia, Deepen S Gandhi
RÉSUMÉ

Here in we tried to increase an antibacterial activity of ciprofloxacin drug due to formation of mixed-ligand complexes. Synthesized compounds were found to be more potent compare to drugs, ligands and metal salt against selective gram((+ve)) and gram((-ve)) organisms. Interaction of the complexes with nucleic acid (DNA) were investigated using spectroscopic technique, viscosity measurement and gel electrophoresis and it was found that the complexes bind to DNA via intercalative mode.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
o-Phenylenediamine, flaked, 99.5%
Sigma-Aldrich
Levofloxacin, 98.0-102.0% anhydrous basis (HPLC)
Sigma-Aldrich
o-Phenylenediamine, Peroxidase substrate, ≥98.0%, powder
Sigma-Aldrich
Ofloxacin, fluoroquinolone antibiotic
Sigma-Aldrich
Éthylènediamine, ReagentPlus®, ≥99%
Sigma-Aldrich
Éthylènediamine, purified by redistillation, ≥99.5%
Sigma-Aldrich
Ciprofloxacin, ≥98% (HPLC)
Sigma-Aldrich
1,8-Diaminonaphthalene, 99%
Sigma-Aldrich
o-Phenylenediamine, tablet, 20 mg substrate per tablet
Sigma-Aldrich
Éthylènediamine, BioXtra
Sigma-Aldrich
Sparfloxacine, ≥98.0% (HPLC)
Sigma-Aldrich
Éthylènediamine, puriss. p.a., absolute, ≥99.5% (GC)
Sigma-Aldrich
Ethylenediamine solution, technical, 75-80%
Sigma-Aldrich
Enrofloxacin, ≥99.0%
Supelco
Norfloxacin, analytical standard, ≥98% (TLC)
Supelco
Éthylènediamine, analytical standard
Supelco
Ciprofloxacin, VETRANAL®, analytical standard
Supelco
Enrofloxacin, VETRANAL®, analytical standard
Sigma-Aldrich
Éthylènediamine, meets USP testing specifications
Supelco
Norfloxacin, VETRANAL®, analytical standard
Supelco
Ofloxacin, VETRANAL®, analytical standard